Quadrivalent flu vaccine trial for adults
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new quadrivalent influenza (flu) vaccine in adults 18 and older. It aims to see if the vaccine is safe and helps protect against the flu. You may be able to join if you are generally healthy and have not had the flu or a flu shot recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have a valid ID.
- You understand the study and have given your signed consent.
- Your temperature is 37.0°C (98.6°F) or lower on the day you join.
- If you could become pregnant or get someone pregnant, you must agree to use effective birth control for 6 months after the vaccine.
- You have not had the flu in the past 6 months.
- You are not allergic to eggs or any part of the vaccine, and have no history of severe allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new flu vaccine to see how well it protects adults aged 18 to 64. If you join, you'll get the vaccine and have some check-ups to see how your body responds.
This study tests an investigational flu vaccine to see how well it protects against seasonal flu. It is for people ages 3 and older who have had a flu shot in the past year (for children ages 3–8) or have not had one recently (for ages 9+). The study will last several months and involves a few clinic visits.
This study tests a new flu vaccine in adults aged 65 and older to see how well it prevents the flu. If you are generally healthy or manage chronic conditions well, you may be able to join.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This trial tests an experimental flu shot that includes an adjuvant (an ingredient that boosts the immune response). It aims to see if the shot is safe and how well it works in adults. Participation lasts for a few months and involves blood tests and a review of any side effects.
Hear when a new Influenza, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.